Wolverine Trading, LLC Clovis Oncology, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $2,646 - $12,432	-4,200 Reduced 6.85%	57,100 $98,000
Q1 2022 May 16, 2022	SELL	$1.43 - $3.14 $12,012 - $26,376	-8,400 Reduced 12.05%	61,300 $101,000
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $270 - $476	100 Added 0.14%	69,700 $199,000
Q3 2021 Nov 12, 2021	SELL	$4.06 - $5.8 $222,487 - $317,840	-54,800 Reduced 44.05%	69,600 $315,000
Q2 2021 Aug 06, 2021	BUY	$5.02 - $7.05 $5,521 - $7,755	1,100 Added 0.89%	124,400 $728,000
Q1 2021 May 14, 2021	BUY	$4.81 - $10.34 $43,290 - $93,060	9,000 Added 7.87%	123,300 $836,000
Q4 2020 Feb 12, 2021	BUY	$4.13 - $6.41 $34,279 - $53,203	8,300 Added 7.83%	114,300 $562,000
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $172,074 - $275,604	35,700 Added 50.78%	106,000 $630,000
Q2 2020 Aug 13, 2020	BUY	$5.69 - $9.69 $400,007 - $681,207	70,300 New	70,300 $494,000
Q4 2019 Feb 12, 2020	SELL	$3.0 - $16.43 $157,500 - $862,575	-52,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $88,032 - $343,840	-22,400 Reduced 29.91%	52,500 $210,000
Q2 2019 Aug 20, 2019	BUY	$12.81 - $25.67 $367,647 - $736,729	28,700 Added 62.12%	74,900 $1.11 Million
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $102,428 - $175,624	-5,800 Reduced 11.15%	46,200 $1.15 Million
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $154,679 - $434,511	-13,300 Reduced 20.37%	52,000 $934,000
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $1 Million - $1.69 Million	34,100 Added 109.29%	65,300 $1.92 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $285,684 - $386,004	-5,700 Reduced 15.45%	31,200 $1.65 Million
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $294,219 - $431,358	-5,100 Reduced 12.14%	36,900 $2.51 Million
Q3 2017 Nov 15, 2017	BUY	$67.17 - $84.81 $2.82 Million - $3.56 Million	42,000	42,000 $3.46 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account